Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints-Reference-Cited by-同舟云学术

Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints

Published:2018-11-15 Issue:12 Volume:27 Page:1371-1378
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Zielinski G. Denise¹^ORCID,Teichert Martina²,Klok Frederikus A.³,Rosendaal Frits R.¹,Huisman Menno V.³,Cannegieter Suzanne C.¹³,Lijfering Willem M.¹

Affiliation:

1. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden The Netherlands

2. Department of Clinical Pharmacy and Toxicology; Leiden University Medical Center; Leiden The Netherlands

3. Department of Thrombosis and Haemostasis; Leiden University Medical Center; Leiden The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4684/fullpdf

Reference37 articles.

1. Verdubbeling van gebruik nieuwe antistollingsmiddelen 2016 151 14 https://www.sfk.nl/nieuws-publicaties/PW/2016/verdubbeling-van-gebruik-nieuwe-antistollingsmiddelen. Accessed 14-02-201

2. Treatment changes among users of non-vitamin K antagonist oral anticoagulants in atrial fibrillation;Hellfritzsch;Basic Clin Pharmacol Toxicol,2017

3. When are observational studies as credible as randomised trials?;Vandenbroucke;Lancet,2004

4. The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) study;Connolly;Circulation,2013

5. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial;Bytzer;Clin Gastroenterol Hepatol,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians;Expert Review of Cardiovascular Therapy;2024-09-12

2. Oral Anticoagulants, Proton Pump Inhibitors, and Fracture;JAMA Internal Medicine;2020-04-01